Doctor profile · Federal record

Dr. Marina Litvin, MD

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Internal Medicine Physician · Saint Louis, MO

  • NPI 1154581775
  • Accepts Medicare
  • MIPS 79.3 / 100 · 2023
  • 18 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
4921 Parkview Pl, Div Im Endocrinology, Ste 13B
Saint Louis, MO 631101032
(314) 362-3500
fax (314) 230-1119
Mailing address
Po Box 7412011
Chicago, IL 606742011

Credentials & registration

NPPES · NUCC
NPI registered
June 2008 — 18 yrs on file
Profile last updated
April 17, 2025
Year of graduation
2008 — 18 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Missouri #2013016098
Medicaid
MO #200005550

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1154581775. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,222
Distinct HCPCS
10
Medicare allowed
$79,217
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 486 282 $124
83036 Hemoglobin a1c level 227 134 $9
82962 Blood glucose (sugar) test performed by hand-held instrument 139 107 $3
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 123 66 $33
99213 Established patient office or other outpatient visit, 20-29 minutes 71 59 $86
82947 Blood glucose (sugar) level 42 35 $4
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 38 26 $63
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 37 11 $20
99441 Telephone medical discussion with physician, 5-10 minutes 23 21 $54
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 19 18 $77

In context: peer comparison

Among 33 peers in this city , average services per provider: 421. This provider delivers 2.9× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$258
Transactions
3
Manufacturers
2
Payer (manufacturer) Industry Txns Amount
Novo Nordisk Inc 2 $135.35
Amgen Inc. 1 $122.43

By nature of payment

Food and Beverage
$258

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,547
Patients
388
Total drug cost
$829,691
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 429 106 $7,808
Ozempic (Semaglutide) Brand 186 36 $236,866
Trulicity (Dulaglutide) Brand 133 20 $156,548
Metformin Hcl Er (Metformin Hcl) Brand 111 33 $2,147
Metformin Hcl Generic 101 30 $1,125
Jardiance (Empagliflozin) Brand 88 24 $95,581
Mounjaro (Tirzepatide) Brand 69 13 $81,965
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 63 23 $39,079
Atorvastatin Calcium Generic 59 20 $784
Tresiba Flextouch U-200 (Insulin Degludec) Brand 54 0 $47,245

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Marina Litvin's medical specialty?
Dr. Marina Litvin practices Endocrinology, Diabetes & Metabolism Physician in Saint Louis, MO.
Where does Dr. Marina Litvin practice?
Dr. Marina Litvin practices at 4921 Parkview Pl, Saint Louis, MO 631101032. Office phone: 3143623500.
What is Dr. Marina Litvin's NPI?
Dr. Marina Litvin's National Provider Identifier (NPI) is 1154581775, issued by NPPES.
Does Dr. Marina Litvin accept Medicare assignment?
Yes. Dr. Marina Litvin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Marina Litvin commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962). Source: CMS Medicare Physician & Other Practitioners file.